Prevenar

Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years
Yahoo/BusinessWire
Sun, 04/28/13 - 12:23 pm
Pfizer
Prevenar
pneumococcal disease
vaccines